Beyond Air, Inc. Payments to Acquire Marketable Securities
Beyond Air, Inc. (XAIR) reported Payments to Acquire Marketable Securities of $40.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-13
- Beyond Air, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $40.00K, a 1233.33% increase year-over-year.
- Beyond Air, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $41.00K.
- Beyond Air, Inc. payments to acquire marketable securities for the quarter ending 2025-06-30 was $3.00K, a 99.98% decline year-over-year.
- Beyond Air, Inc. payments to acquire marketable securities for the quarter ending 2025-03-31 was $0.00.
- Beyond Air, Inc. payments to acquire marketable securities for fiscal 2026 was $4.05M, a 86.87% decline from fiscal 2025.
- Beyond Air, Inc. payments to acquire marketable securities for fiscal 2025 was $30.88M.
- Beyond Air, Inc. payments to acquire marketable securities for fiscal 2023 was $35.66M.
- Beyond Air, Inc. payments to acquire marketable securities for fiscal 2020 was $37.32M, a 205.33% increase from fiscal 2019.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 3 month as first filed | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 6 month as first filed | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40.00K 10-Q · filed 2026-08-13 | $81.00K derived: sum of 2 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $4.05M 10-K · filed 2026-06-26 | ||||
| 2025-12-31 | $4.01M 10-Q · filed 2026-02-13 | |||||
| 2025-06-30 | $3.00K 10-Q · filed 2026-08-13 | $3.00K derived: sum of 2 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $30.88M 10-K · filed 2026-06-26 | ||||
| 2024-12-31 | $30.88M 10-Q · filed 2026-02-13 | |||||
| 2024-06-30 | $14.57M 10-Q · filed 2024-08-06 | |||||
| 2023-06-30 | $9.74M 10-Q · filed 2024-08-06 | $12.62M derived: sum of 2 quarters · filed 2024-08-06 | $12.78M derived: sum of 3 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | $3.04M derived: sum of 2 quarters · filed 2023-06-22 | $35.66M 10-K · filed 2023-06-22 | |||
| 2022-12-31 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-10 | $32.78M 10-Q · filed 2023-02-10 | ||||
| 2022-09-30 | $32.62M 10-Q · filed 2022-11-08 | |||||
| 2020-03-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10 | $25.46M derived: sum of 2 quarters · filed 2021-06-10 | $20.86M derived: sum of 3 quarters · filed 2021-06-10 | $37.32M 10-K · filed 2021-06-10 | ||
| 2019-12-31 | $21.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | $16.51M derived: sum of 2 quarters · filed 2021-02-09 | $32.97M 10-Q · filed 2021-02-09 | |||
| 2019-09-30 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | $11.86M 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $16.46M 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $12.22M 10-K · filed 2020-06-23 | |||||
| 2018-09-30 | $27.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | $60.89K 10-Q · filed 2019-11-06 | $61.00K 10-Q · filed 2018-11-14 | $9.46M derived: sum of 3 quarters · filed 2019-11-06 | $8.07M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | $33.00K 10-Q · filed 2019-08-14 | $9.44M derived: sum of 2 quarters · filed 2019-08-14 | $8.04M derived: sum of 3 quarters · filed 2019-08-14 | $10.04M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $9.40M 10-K · filed 2019-06-28 | $9.40M 10-KT · filed 2018-06-15 | $8.01M derived: sum of 2 quarters · filed 2019-06-28 | $10.01M derived: sum of 3 quarters · filed 2019-06-28 | $8.30M 10-K · filed 2019-06-28 | |
| 2017-12-31 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | $603.86K derived: sum of 2 quarters · filed 2019-02-14 | $603.86K 10-Q · filed 2019-02-14 | $2.00M 10-K · filed 2019-06-28 | ||
| 2017-09-30 | $2.00M 10-Q · filed 2017-11-03 | $2.00M 10-Q · filed 2018-11-14 | $2.00M 10-Q · filed 2017-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |